Brynjelsen Sean's Form 4 filing
Eton Pharmaceuticals, Inc.ETON · filed Aug 20, 2026
- Accession no.
- 0001437749-26-028651
- Filed
- Aug 20, 2026, 6:26 PM ET
- Trade date
- Aug 19-20, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $6.09M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brynjelsen SeanCIK 0001669976 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Common Stock | SSaleDisposed | −8,978 | $62.65F1,F2 | −$562,471.7 | 1,052,216 | Direct | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −47,307 | $60.17F2,F3 | −$2,846,462.19 | 1,004,909 | Direct | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −36,373 | $61.11F2,F4 | −$2,222,754.03 | 968,536 | Direct | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −7,342 | $62.12F2,F5 | −$456,085.04 | 961,194 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares were sold in multiple trades at prices ranging from $62.50 to $63.41. The price above reflects the weighted average sales price.
Referenced by the price of 1 transaction in Table I.
- F2
The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 4 transactions in Table I.
- F3
The shares were sold in multiple trades at prices ranging from $59.59 to $60.59. The price above reflects the weighted average sales price.
Referenced by the price of 1 transaction in Table I.
- F4
The shares were sold in multiple trades at prices ranging from $60.61 to $61.61. The price above reflects the weighted average sales price.
Referenced by the price of 1 transaction in Table I.
- F5
The shares were sold in multiple trades at prices ranging from $61.63 to $62.52. The price above reflects the weighted average sales price.
Referenced by the price of 1 transaction in Table I.